MYR Group reports Q2 results today having shed 33% over the past month to $322.06, extending the brutal drawdown previewed yesterday and forcing the question that now dominates the setup: has the selling run ahead of the fundamentals, or is the market correctly pricing in a genuine margin deterioration?
Options positioning argues firmly for the former being far from settled. The put/call ratio is running at 4.10 — well above its 20-day average of 3.71 and approaching the 52-week high of 4.36. That ratio has climbed sharply since mid-July, when it sat closer to 3.3, and the z-score of 1.02 confirms the defensive skew is real rather than noise. Peers have also sold off hard on the week — PWR dropped 8%, MTZ fell 11%, and ECG slid 14% — suggesting sector-wide pressure rather than a MYRG-specific collapse. Even so, MYRG's 21% weekly decline has outpaced all of them, pointing to something stock-specific amplifying the damage.
The bull and bear cases head into the print in genuine tension. Bulls point to a multi-year structural tailwind from transmission and distribution buildout, and the fact that MYRG's prior Q1 print delivered a 28% single-day rally after the company appeared to have put execution problems behind it. The consensus price target of $445.50 implies nearly 40% upside from current levels, and Cantor Fitzgerald raised its target to $564 in May after maintaining an Overweight. Bears counter that margin assumptions have already been revised lower for both the T&D and commercial and industrial segments, with weather, sequencing, and regulatory permitting all cited as ongoing risks — precisely the kind of headwinds that can compound in a weak quarter. Goldman Sachs remains at Neutral with a $296 target struck in March, well below the current price; that note is now stale by several months, but the cautiousness it reflected has aged well given the stock's path since.
The insider picture adds a layer of context worth noting. Directors and the CFO collectively sold roughly $6.6 million of stock in early June at prices around $450 — about 40% above today's close. That selling came after the Q1 rally and does not necessarily signal concern about the business, but it does mean insiders were reducing exposure near the highs rather than adding into the weakness. Borrow availability remains extremely loose at over 1,170% and the short score has drifted lower all week to 38.9, consistent with shorts quietly reducing rather than pressing the thesis harder.
Today's print is therefore less about whether MYRG's end markets remain healthy and more about whether Q2 margins show the execution stabilisation bulls have been pricing in — or confirm that the project-level headwinds bears have flagged are eating deeper into profitability than the post-Q1 optimism assumed.
See the live data behind this article on ORTEX.
Open MYRG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.